The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs

Faye Lanni; Neil Burton; Debbie Harris; Susan Fotheringham; Simon Clark; Oliver Skinner; Nathan Wiblin; Mike Dennis; Stuart Armstrong; Geraint Davies; Ann Williams

doi:10.1371/journal.pone.0245922

The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs

Faye Lanni^*, Neil Burton, Debbie Harris, Susan Fotheringham, Simon Clark, Oliver Skinner, Nathan Wiblin, Mike Dennis, Stuart Armstrong, Geraint Davies, Ann Williams

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

10 Downloads (Pure)

Abstract

Optimised pre-clinical models are required for TB drug development to better predict the pharmacokinetics of anti-tuberculosis (anti-TB) drugs to shorten the time taken for novel drugs and combinations to be approved for clinical trial. Microdialysis can be used to measure unbound drug concentrations in awake freely moving animals in order to describe the pharmacokinetics of drugs in the organs as a continuous sampling technique. The aim of this work was to develop and optimise the microdialysis methodology in guinea pigs to better understand the pharmacokinetics of rifampicin in the lung. In vitro experiments were performed before progressing into in vivo studies because the recovery (concentration of the drug in the tissue fluid related to that in the collected dialysate) of rifampicin was dependent on a variety of experimental conditions. Mass spectrometry of the dialysate was used to determine the impact of flow rate, perfusion fluid and the molecular weight cut-off and membrane length of probes on the recovery of rifampicin at physiologically relevant concentrations. Following determination of probe efficiency and identification of a correlation between rifampicin concentrations in the lung and skeletal muscle, experiments were conducted to measure rifampicin in the sacrospinalis of guinea pigs using microdialysis. Lung concentrations of rifampicin were estimated from the rifampicin concentrations measured in the sacrospinalis. These studies suggest the potential usefulness of the microdialysis methodology to determine drug concentrations of selected anti-TB drugs to support new TB drug development.

Original language	English
Article number	0245922
Number of pages	11
Journal	PLoS ONE
Volume	16
Issue number	1
DOIs	https://doi.org/10.1371/journal.pone.0245922
Publication status	Published - 22 Jan 2021

Bibliographical note

Funding Information: This work was supported by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Author Neil Burton is affiliated to Q3 Analytical but provided his time for this study for free. Q3 Analytical provided support in the form of salaries for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.

Open Access: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publisher Copyright: © 2021 Lanni et al.

Citation: Lanni F, Burton N, Harris D, Fotheringham S, Clark S, Skinner O, et al. (2021) The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs. PLoS ONE 16(1): e0245922.

DOI: https://doi.org/10.1371/journal.pone.0245922

Keywords

SKELETAL-MUSCLE
TUBERCULOSIS
PENETRATION
PHARMACODYNAMICS
PHARMACOKINETICS
AGENTS
MODEL

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0245922Licence: CC BY

Lanni2021ThePotentialOfMicrodialysisToEstimateRifampicinConcentrationsPLoSONEFinal published version, 1 MBLicence: CC BY

Cite this

@article{28650a3d82b74771aafb7f8c5af3c1aa,

title = "The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs",

abstract = "Optimised pre-clinical models are required for TB drug development to better predict the pharmacokinetics of anti-tuberculosis (anti-TB) drugs to shorten the time taken for novel drugs and combinations to be approved for clinical trial. Microdialysis can be used to measure unbound drug concentrations in awake freely moving animals in order to describe the pharmacokinetics of drugs in the organs as a continuous sampling technique. The aim of this work was to develop and optimise the microdialysis methodology in guinea pigs to better understand the pharmacokinetics of rifampicin in the lung. In vitro experiments were performed before progressing into in vivo studies because the recovery (concentration of the drug in the tissue fluid related to that in the collected dialysate) of rifampicin was dependent on a variety of experimental conditions. Mass spectrometry of the dialysate was used to determine the impact of flow rate, perfusion fluid and the molecular weight cut-off and membrane length of probes on the recovery of rifampicin at physiologically relevant concentrations. Following determination of probe efficiency and identification of a correlation between rifampicin concentrations in the lung and skeletal muscle, experiments were conducted to measure rifampicin in the sacrospinalis of guinea pigs using microdialysis. Lung concentrations of rifampicin were estimated from the rifampicin concentrations measured in the sacrospinalis. These studies suggest the potential usefulness of the microdialysis methodology to determine drug concentrations of selected anti-TB drugs to support new TB drug development.",

keywords = "SKELETAL-MUSCLE, TUBERCULOSIS, PENETRATION, PHARMACODYNAMICS, PHARMACOKINETICS, AGENTS, MODEL",

author = "Faye Lanni and Neil Burton and Debbie Harris and Susan Fotheringham and Simon Clark and Oliver Skinner and Nathan Wiblin and Mike Dennis and Stuart Armstrong and Geraint Davies and Ann Williams",

note = "Funding Information: This work was supported by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Author Neil Burton is affiliated to Q3 Analytical but provided his time for this study for free. Q3 Analytical provided support in the form of salaries for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the {\textquoteleft}author contributions{\textquoteright} section. Open Access: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Publisher Copyright: {\textcopyright} 2021 Lanni et al. Citation: Lanni F, Burton N, Harris D, Fotheringham S, Clark S, Skinner O, et al. (2021) The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs. PLoS ONE 16(1): e0245922. DOI: https://doi.org/10.1371/journal.pone.0245922",

year = "2021",

month = jan,

day = "22",

doi = "10.1371/journal.pone.0245922",

language = "English",

volume = "16",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "1",

}

TY - JOUR

T1 - The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs

AU - Lanni, Faye

AU - Burton, Neil

AU - Harris, Debbie

AU - Fotheringham, Susan

AU - Clark, Simon

AU - Skinner, Oliver

AU - Wiblin, Nathan

AU - Dennis, Mike

AU - Armstrong, Stuart

AU - Davies, Geraint

AU - Williams, Ann

N1 - Funding Information: This work was supported by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Author Neil Burton is affiliated to Q3 Analytical but provided his time for this study for free. Q3 Analytical provided support in the form of salaries for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. Open Access: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Publisher Copyright: © 2021 Lanni et al. Citation: Lanni F, Burton N, Harris D, Fotheringham S, Clark S, Skinner O, et al. (2021) The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs. PLoS ONE 16(1): e0245922. DOI: https://doi.org/10.1371/journal.pone.0245922

PY - 2021/1/22

Y1 - 2021/1/22

N2 - Optimised pre-clinical models are required for TB drug development to better predict the pharmacokinetics of anti-tuberculosis (anti-TB) drugs to shorten the time taken for novel drugs and combinations to be approved for clinical trial. Microdialysis can be used to measure unbound drug concentrations in awake freely moving animals in order to describe the pharmacokinetics of drugs in the organs as a continuous sampling technique. The aim of this work was to develop and optimise the microdialysis methodology in guinea pigs to better understand the pharmacokinetics of rifampicin in the lung. In vitro experiments were performed before progressing into in vivo studies because the recovery (concentration of the drug in the tissue fluid related to that in the collected dialysate) of rifampicin was dependent on a variety of experimental conditions. Mass spectrometry of the dialysate was used to determine the impact of flow rate, perfusion fluid and the molecular weight cut-off and membrane length of probes on the recovery of rifampicin at physiologically relevant concentrations. Following determination of probe efficiency and identification of a correlation between rifampicin concentrations in the lung and skeletal muscle, experiments were conducted to measure rifampicin in the sacrospinalis of guinea pigs using microdialysis. Lung concentrations of rifampicin were estimated from the rifampicin concentrations measured in the sacrospinalis. These studies suggest the potential usefulness of the microdialysis methodology to determine drug concentrations of selected anti-TB drugs to support new TB drug development.

AB - Optimised pre-clinical models are required for TB drug development to better predict the pharmacokinetics of anti-tuberculosis (anti-TB) drugs to shorten the time taken for novel drugs and combinations to be approved for clinical trial. Microdialysis can be used to measure unbound drug concentrations in awake freely moving animals in order to describe the pharmacokinetics of drugs in the organs as a continuous sampling technique. The aim of this work was to develop and optimise the microdialysis methodology in guinea pigs to better understand the pharmacokinetics of rifampicin in the lung. In vitro experiments were performed before progressing into in vivo studies because the recovery (concentration of the drug in the tissue fluid related to that in the collected dialysate) of rifampicin was dependent on a variety of experimental conditions. Mass spectrometry of the dialysate was used to determine the impact of flow rate, perfusion fluid and the molecular weight cut-off and membrane length of probes on the recovery of rifampicin at physiologically relevant concentrations. Following determination of probe efficiency and identification of a correlation between rifampicin concentrations in the lung and skeletal muscle, experiments were conducted to measure rifampicin in the sacrospinalis of guinea pigs using microdialysis. Lung concentrations of rifampicin were estimated from the rifampicin concentrations measured in the sacrospinalis. These studies suggest the potential usefulness of the microdialysis methodology to determine drug concentrations of selected anti-TB drugs to support new TB drug development.

KW - SKELETAL-MUSCLE

KW - TUBERCULOSIS

KW - PENETRATION

KW - PHARMACODYNAMICS

KW - PHARMACOKINETICS

KW - AGENTS

KW - MODEL

UR - http://www.scopus.com/inward/record.url?scp=85100029466&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0245922

DO - 10.1371/journal.pone.0245922

M3 - Article

C2 - 33481939

AN - SCOPUS:85100029466

SN - 1932-6203

VL - 16

JO - PLoS ONE

JF - PLoS ONE

IS - 1

M1 - 0245922

ER -

The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this